CompletedPhase 2NCT03942406

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

Studying Whooping cough

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ILiAD Biotechnologies
Principal Investigator
Mary B Manning, MD
Rapid Medical Research Inc
Intervention
BPZE1 pertussis vaccine and VaxINator(TM) Atomization Device(combination_product)
Enrollment
300 enrolled
Eligibility
18-50 years · All sexes
Timeline
20192020

Study locations (3)

Collaborators

PPD Development, LP

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03942406 on ClinicalTrials.gov

Other trials for Whooping cough

Additional recruiting or active studies for the same condition.

See all trials for Whooping cough

← Back to all trials